Fenozolone
Group of stereoisomers
Pharmaceutical compound
|  | |
|  | |
| Clinical data | |
|---|---|
| Routes of administration | Oral | 
| ATC code | |
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
 | 
| UNII | |
| KEGG | 
 | 
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.035.747  | 
| Chemical and physical data | |
| Formula | C11H12N2O2 | 
| Molar mass | 204.229 g·mol−1 | 
| 3D model (JSmol) | |
| Chirality | Racemic mixture | 
| 
 | |
| 
 | |
| (verify) | |
Fenozolone (Ordinator) was developed by Laboratoires Dausse in the 1960s[1] and is a psychostimulant related to pemoline.[2]
See also
[edit]References
[edit]- ^ DE 1297108, Beil W, Hoeppener A, Wolff HJ, "5-phenyl-2-ethylamino-4-oxazolinone and its preparation", issued 12 June 1969, assigned to Les Laboratoires Dausse SA
- ^ Gielsdorf W (February 1982). "Determination of the psychostimulants pemoline, fenozolone and thozalinone in human urine by gas chromatography/mass spectrometry and thin layer chromatography". Journal of Clinical Chemistry and Clinical Biochemistry. 20 (2): 65–8. doi:10.1515/cclm.1982.20.2.65. PMID 6121837. S2CID 38935748. Archived from the original on 2021-05-31. Retrieved 2021-05-31.
|  | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. | 
